The molecular pathogenesis of endotoxic shock and organ failure
Authors:
- Shigeru MatsumotoSMShigeru Matsumoto
- Hidemitsu HigashiHHHidemitsu Higashi
- Kouji MatsushimaKMKouji Matsushima
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 5 (3) , 123-132
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.Journal of Clinical Investigation, 1998
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Predicting Bacteremia in Patients with Sepsis SyndromeThe Journal of Infectious Diseases, 1997
- The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemiaEuropean Journal of Clinical Investigation, 1997
- HEMOSTATIC PARAMETERS IN SEPSIS PATIENTS TREATED WITH ANTI-TNF±-MONOCLONAL ANTIBODIESShock, 1996
- Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.Journal of Clinical Investigation, 1995
- Interleukin‐4 and ‐10 exacerbate candidiasis in miceEuropean Journal of Immunology, 1995
- Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trialCritical Care Medicine, 1994
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.Journal of Experimental Medicine, 1988